Category Archives: Sales of shares

BVI Group announces admission of Common Shares

Eco (Atlantic) Oil & Gas Ltd, BVI-incorporated Group having interests in Guyana and Namibia, announced that the admission of the 250,000 Common Shares will now become effective, and trading on AIM will start on January 22, 2020.

This announcement followed the options exercise announced previously, on January 9,2020. As it was stated in the exercise of options, following the admission the enlarged issued share capital of the BVI company will be 184,697,723 Common Shares.

Eco (Atlantic) Oil & Gas Ltd is a TSX-V and AIM quoted oil & gas exploration and production Company aiming to deliver material value for its stakeholders through exploration, appraisal and development activities in stable emerging markets, in partnership and co-operation with such oil companies, including Tullow, Total and Azinam.

Premier African Minerals successfully closed fundraise on PrimaryBid

BVI-registered corporation Premier African Minerals Limited announced the launch of an offer via the PrimaryBid, which was successfully completed and closed on 11 December 2019. After the closing of the offer, the BVI company has raised gross proceeds of £262,293.00 at an issue price 0.1 pence per ordinary share via the Fundraising. To satisfy the Fundraising, Premier African Minerals has issued 262,293,000 New Ordinary Shares, and the application will be made for them to be admitted to trading on AIM. The shares are expected to be admitted to trading on December 18, 2019. Following the issue of the New Ordinary Shares, the company will have 11,266,071,580 ordinary shares of nil par value in issue.

CEO of the company George Roach said in his comments: “With our Zimbabwean operations being on the verge of hopefully turning a corner, we believe that this was a good opportunity for investors to participate in a fundraise on the retail friendly platform of PrimaryBid. We wish to express our sincerest appreciation to all participants in this successful fundraise.”

21Vianet Group entered into share purchase agreement with BVI-registered Personal Group Limited

21Vianet Group, Inc., a leading carrier- and cloud-neutral Internet data center services provider in China, entered into an agreement with Personal Group Limited, the company registered in the British Virgin Islands and wholly owned by Mr. Sheng Chen, the Executive Chairman of the Board of Directors of 21Vianet Group. Under the terms of the agreement, the Chinese company will issue up to 60,000 newly created Class C ordinary shares to Personal Group Limited, at a price of US$1.35 per share and subject to certain existing shareholders’ participation right. The issuance has been approved by the company’s audit committee and board of directors.

Under the investor right agreement, two of the existing shareholders of 21Vianet Group, King Venture Holdings Limited and Xiaomi Ventures Limited, have the participation right to subscribe up to 5,049 and 1,468 Class C ordinary shares, respectively, on the same terms as the Purchaser; if their participation right will be exercised, the number of shares issued to the BVI company will be reduced accordingly.

Juvenescence Ltd raised US$46mln in funding

Investment company FastForward Innovations Ltd announced that its investee, BVI-based biotech firm Juvenescence Ltd, has completed the first part of its funding round, having raised US46mln at US$24.70 per share. In total, the BVI company plans to raise between US$100mln to US$125mln.

FastForward Chief Executive Lorne Abony said: “We are delighted with the progress Juvenescence is making with the pipeline of drugs, therapies and technologies they are developing. Having spent time with the company’s management in the past few weeks in San Francisco I share their optimism in relation to near-term potential of the company… The successful initial public offer of Age-X Therapeutics in which Juvenescence has a 46% interest, is a great example of the expertise Juvenescence brings to drug development companies.”

The price of the Series B funding values Juvenescence at US$400mln, which is 58% premium to the price at which FastForward invested in the company’s Series A funding.